After waging on for a year now, and leaving million infected, many dead and economies trembling, there seems to be hope against the coronavirus pandemic as potential vaccines, with higher rates of efficacy have been researched.
This is the first time in human history that a vaccine has been found so quickly. Many of these vaccines are results of cross-national efforts and boasts more than 90% effectiveness and no severely adverse side effects.
Scientists have been working to determine whether or not these vaccine are effective and are safe for human use. Many of the leading drugmakers' vaccines are getting emergency use approval and some have even got full approval from country level top medicine regulation body.
Here are the leading Covid-19 vaccines and the countries that have approved them for use:
China's Sinovac Biotech's Covid-19 vaccine, CoronaVac got emergency use authorisation by the country's National Health Commission on July of this year.
It has yet to get full authorisation.
Co-developed by China's Sinopharm, Beijing Institute of Biological Products and Wuhan Institute of Biological Products, the BBIBP-CorV is an inactivated virus Covid-19 vaccines.
China's National Health Commission approved the emergency use on July of this year.
On 9 December, United Arab Emirates' ministry of health approved full authorisation of the vaccine. Bahrain on 13 December also gave the Sinopharm's vaccine full authorisation.
Egypt recently gave it emergency approval.
Sputnik-V, developed by Russia's Gamaleya Research Institute of Epidemiology and Microbiology was the first to claim effectiveness against the Covid-19.
Russia's ministry of health on 11 August gave the vaccine emergency authorisation.
Other than Russia, five other countries - Belarus Argentina, Bolivia, Venezuela and Serbia have approved it for emergency use.
Co-developed by Bharat Biotech and Indian Council of Medical Research, it was granted emergency approval in India.
Developed by BioNTech, Pfizer and Fosun Pharma, the vaccine claimed 95% effectiveness.
Its development process was unprecedentedly fast — no other vaccine in history has been created and manufactured so quickly.
On 2 December, it got emergency approval in the UK, with Bahrain and Canada doing the same on 5 and 9 December respective.
The US FDA gave the vaccine emergency authorisation on 11 December. Mexico also approved the same day.
Middle East's Kuwait granted Pfizer vaccine emergency use on 13 December. Singapore on 14 December permitted emergency use for it.
Latest to grant it emergency authorisation are
Jordan, Oman, Costa Rica, Ecuado, Israel, Panama, Chile, Qatar, UAE, Argentina Iraq and the WHO.
Saudi Arabia, Switzerland, the EU, Norway, Iceland, the Faroe Islands, Greenland and Serbia have given it full authorisation.
Developed by the UK's University of Oxford and AstraZeneca, the vaccine agent uses modified chimpanzee adenovirus vector.
UK, Argentina, India and El Salvador granted it emergency use approval.
It currently awaits emergency use approval in Canada.
The US drugmaker's vaccine uses lipid nanoparticle dispersion containing modRNA in its agent and currently has been given emergency approval in US and Canada.
Johnson & Johnson Vaccine
The non-replicating viral vector based vaccine currently awaits emergency approval in Canada.